Benzbromarone is not recommended for treatment of gout attacks. Benzbromarone is a benzofuran derivative that can reduce blood uric acid level by inhibiting the reabsorption of uric acid in the renal tubules. Since the drug can effectively reduce the blood uric acid level, the lowering of uric acid in the blood will lead to the leaching of uric acid from the tissues and thus aggravate the symptoms of gout, therefore, it is not recommended to take Benzbromarone during gouty attack treatment. In order to avoid an acute gout attack at the beginning of benzbromarone treatment, colchicine or non-steroidal anti-inflammatory drugs (NSAIDs) such as etoricoxib, meloxicam, celecoxib, etc., can be taken as a preventive measure at the beginning of the treatment, and plenty of water should be consumed during the medication period in order to avoid the formation of uric acid crystals. Common adverse effects of taking benzbromarone are gastrointestinal discomfort such as nausea, vomiting, feeling of fullness in the stomach and diarrhea. Benzbromarone is contraindicated in people who are allergic to any of the ingredients in this product, people with moderate to severe renal impairment (glomerular filtration rate less than 20 ml/min) and patients suffering from renal stones, pregnant women, women who are likely to become pregnant, and breastfeeding women. Note that for long-term use, liver function should be checked regularly and concomitant use with other drugs for liver damage should be avoided. Benzbromarone should be used under the guidance of a physician, and gout patients are advised to go to the rheumatology and immunology department of a regular hospital for detailed consultation.